Personalis, Inc.

PSNL Healthcare Diagnostics & Research

Personalis, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $69.6 million, down 17.7% from fiscal 2024. In the quarter to June 2026, revenue grew 30.0%, EPS fell 30.4% and free cash flow fell 123.5%, each against the same quarter a year earlier. Insiders bought in the last twelve months.

15.65 0.28 −1.76%
Market cap
$1.7B
P/E
0.0×
Fwd P/E
−10.5×
Dividend yield
—
F-score
4/9
Altman Z
3.35
Beneish M
−1.30
Dividend safety
n/a
Older periods Sep '25 Dec '25 Mar '26 Jun '26
Piotroski F-Score

+8 more TTM periods

4 4 3 3
ROE
(43.70%) (35.02%) (41.35%) (50.32%)
ROA
(30.61%) (26.89%) (31.92%) (37.55%)
ROIC
(241.93%) (259.21%) (297.38%) (317.48%)
Return on Tangible Assets
(39.88%) (29.75%) (35.71%) (43.35%)
Average Days of Receivables
75.93 84.91 73.67 79.12
Free Cash Flow per Share
(0.75) (0.89) (0.81) (0.96)
Free Cash Flow
(66.17) (79.45) (84.53) (100.85)
Capital Expenditures
(5.67) (4.50) (5.06) (8.56)
Other line items
Cash ROIC
(20.55%) (15.85%) (17.32%) (22.52%)
Accounts Receivable Turnover
4.96 5.72 5.38 5.56
Accounts Payable Turnover
4.30 5.56 5.41 4.69
Inventory Turnover
7.71 8.92 9.39 8.07
Average Days of Payables
80.29 88.01 83.12 96.03
Days of Inventory on Hand
33.54 41.63 45.44 57.83
Tax Rate
0.00 0.00 0.00 0.00
Research and Development Expense of Revenue
70.45% 72.17% 80.85% 80.55%
Selling, General and Administrative Expense of Revenue
73.29% 76.92% 91.78% 96.21%
Share Based Compensation of Revenue
14.18% 13.54% 15.13% 15.67%
Interest Coverage
(582.04) (429.55) (457.69) (536.66)
Operating CF/Net income
0.82 0.92 0.83 0.86
Depreciation/Fixed assets
0.13 0.14 0.12 0.12
Capex/Depreciation
(0.92) (0.74) (0.87) (1.49)
Revenue per Share
0.78 0.78 0.62 0.66
Operating CF per Share
(0.68) (0.84) (0.76) (0.88)
Capex per Share
(0.06) (0.05) (0.05) (0.08)
Capex to Sales
0.08 0.06 0.08 0.12

Fold the line items

Columns are period end dates